Back to Search Start Over

182P Cancer vaccines based on whole-tumor-lysate or neoepitopes with validated HLA-binding outperform those with predicted HLA-binding affinity

Authors :
L. Kandalaft
H. Fritah
M. Graciotti
C. Chiang
R. Petremand
P. Guillaume
J. Schmidt
B. Stevenson
D. Gfeller
A. Harari
Source :
Immuno-Oncology and Technology. 16:100294
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Oncology
Immunology and Allergy

Details

ISSN :
25900188
Volume :
16
Database :
OpenAIRE
Journal :
Immuno-Oncology and Technology
Accession number :
edsair.doi...........e1b5edf4136e238d8c269b102be910af
Full Text :
https://doi.org/10.1016/j.iotech.2022.100294
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details